NeuroSense Advances Promising ALS Treatment with Potential Global Partnership
Biotech company NeuroSense Therapeutics is in advanced discussions for a pharmaceutical partnership that could accelerate its innovative ALS treatment PrimeC, demonstrating significant survival improvements in clinical trials.
